First new therapy in nearly a decade offers another option for physicians, patients
Richard D. Najac, MD, FACS
Advertisement
Articles by Richard D. Najac, MD, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy
2
STAAR and Broadwood conflict over proposed Alcon merger continues
3
Ocular surface: Targeted therapies for a multifactorial problem
4
Finding your fit: Excimer lasers and early surgical practice
5
.png "Optometry Times"){kind=logo}
